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Background
Delayed onset muscle soreness (DOMS) is muscle pain
and discomfort experienced approximately one to three
days after exercise and is believed to be a result of micro-
scopic muscle fiber tears. The Bounce-Back™ product is a
combination of several dietary supplement ingredients
which have individually been shown to improve the
inflammation and pain associated with DOMS (digestive
enzymes, Bromelain, Curcumin, Vitamin C) in combina-
tion with an Avocado Soy extract and Resveratrol. The pur-
pose of the study was to evaluate the ability of the Bounce-
Back™  product to reduce the signs and symptoms of
DOMS and increase the rate of muscle recovery following
eccentric exercise.
Methods
A randomized, double-blind, placebo-controlled, crosso-
ver study was performed with 10 healthy, untrained sub-
jects between the ages of 18 and 45. Subjects were
screened for eligibility and then randomized to receive the
active or placebo product for 33 days. Subjects wore the
BodyMedia Armband Monitoring System during days 28–
30 to track their pre-exercise activity level. Subjects
returned on day 30 to undergo a standardized eccentric
exercise protocol (isokinetic quadriceps squat contrac-
tions). Subjects underwent pain and tenderness (algom-
eter) evaluations and blood draws just prior to exercise,
immediately post-exercise, and again at 6, 24, 48, and 72
hours post-exercise. Subjects underwent a two-week wash-
out, and were then crossed over to the other arm of the
study. Mean differences between groups were assessed
inferentially at each data collection time-point.
Results
Statistically significant differences were observed in favor
of the Bounce-Back™ product for pain, tenderness, and
amount of energy expended. Immediately post-exercise,
two of the four Visual Analog Scale (VAS) pain assess-
ments were significantly lower (0.35 v 1.0938, p = 0.002
and 0.3095 v. 0.8229, p = 0.047) in the active group. At 6
hours, one of the VAS pain assessments was lower (0.6905
v 1.1146, p = 0.039), and at 48 hours, the total VAS pain
assessment was significantly lower (7.2857 v 13.9821, p =
0.050) in the active group. At 24 hours the tenderness
after algometry was significantly lower (1.7245 v 2.3750,
p = 0.042) in the active group.
Based on the BodyMedia armband data, the active group
recorded significantly greater Total Energy Expenditure
(710.60 v 459.50 METs, p = 0.009) and Measured Active
Energy Expenditure (210.86 v 88.31 METs, p = 0.000).
Serological markers of muscle damage (CPK and
Myoglobin) were lower in the active group throughout
from 2008 International Society of Sports Nutrition Conference and Expo
Las Vegas, NV, USA. 9–10 June 2008
Published: 17 September 2008
Journal of the International Society of Sports Nutrition 2008, 5(Suppl 1):P24 doi:10.1186/1550-2783-5-S1-P24
<supplement> <title> <p>Proceedings of the Fifth International Society of Sports Nutrition (ISSN) Conference and Expo</p> </title> <editor>Paul LaBounty and Jose Antonio</editor> <note>Meeting abstracts – A single PDF containing all abstracts in this Supplement is available <a href=" http://www.biomedcentral.com/content/files/pdf/1550-2783-5-S1-full.pdf">here</a>.</note> </supplement>
This abstract is available from: http://www.jissn.com/content/5/S1/P24
© 2008 Udani et al; licensee BioMed Central Ltd. Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Journal of the International Society of Sports Nutrition 2008, 5(Suppl 1):P24 http://www.jissn.com/content/5/S1/P24
Page 2 of 2
(page number not for citation purposes)
the entire post-exercise period, but this difference did not
reach statistical significance.
Conclusion
In this small pilot study, the Bounce-Back™  product
resulted in a significant reduction in standardized meas-
ures of pain and tenderness post-eccentric exercise, even
after engaging in significantly more activity in the two day
period prior to the exercise protocol. The differences in
the serological markers of DOMS, while not statistically
significant, appear to support the clinical findings. Further
study with a larger sample size is warranted based on the
current results.
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